Atzumi

Active Ingredient(s): Dihydroergotamine Mesylate
FDA Approved: * April 30, 2025
Pharm Company: * SATSUMA PHARMS
Category: Migraine / Tension Headache

Dihydroergotamine (DHE), sold under the brand names D.H.E. 45 and Migranal among others, is an ergot alkaloid used to treat migraines.[5] It is a derivative of ergotamine. It is administered as a nasal spray or injection and has an efficacy similar to that of sumatriptan. Nausea is a common side effect.[6] It has similar actions to the triptans, acting as an agonist to the serotonin receptors and causing vasoconstriction of the intracranial blood vessels, but a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Atzumi 5.2 mg Nasal Powder
NDC: 76978-101
Labeler:
Satsuma Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients